Stock search

Ticker or company name

Compare stocks

Market: US

  • WSTWest Pharmaceutical Services
  • ILMNIllumina, Inc.
  • MTDMettler Toledo

Add stock

Ticker or company

Summary

WST
West Pharmaceutical Services
$417,80Up +0,33%
Year: Up +56%
83/100Best scoreRatio would consider buying
Open stock page
ILMN
Illumina, Inc.
$198,00Down −4,35%
Year: Up +73%
75/100Ratio would consider buying
Open stock page
MTD
Mettler Toledo
$1 727,26Down −0,67%
Year: Up +23%
63/100Ratio would watch
Open stock page

Verdict

WST has the best score (83). WST grows revenue the fastest. MTD is the cheapest by forward P/E. ILMN has the lowest debt load. MTD has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckWST7 ✓ 1 — 1 ✕ILMN5 ✓ 2 — 1 ✕MTD3 ✓ 4 — 1 ✕
P/E vs its history45,5n/a33,636,5
P/E vs industry45,533,636,5
Forward P/E40,539,135,9
Revenue growth, YoY+12,6%+5,8%+6,5%
EPS growth, YoY+32,0%+30,3%+15,0%
Net margin18,8%19,7%22,2%
Net debt / EBITDA−0,3−1,1n/a—
Free cash flow$453 m$1,06 bn$871 m
Share count over a year−2,5%0,0%−2,7%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterWSTTTMILMNTTMMTDTTMIndustry medianTTM
P/E TTM ↓Worst: 45,5Best: 33,636,537,9
Forward P/E ↓Worst: 40,539,1Best: 35,929,5
PEG ↓2,6Worst: 3,4Best: 2,53,7
P/S TTM ↓Worst: 8,6Best: 6,68,16,6
EV/EBITDA ↓Worst: 30,0Best: 26,329,929,9
P/FCF ↓Worst: 64,2Best: 28,539,238,7

Price, %

  • WSTn/a
  • ILMNn/a
  • MTDn/a

Returns

Best WorstNo mark — in between

PeriodWSTILMNMTD
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

WSTILMNMTD
Share of “buy”Best: 95%54%Worst: 47%
Beat the forecast4 of 44 of 44 of 4
Average “surprise”Best: +17,2%+5,8%Worst: +3,2%
Insiders over 12 monthssales $6,57 msales $721 msales $20,3 m

Details are on each stock page.